Matrix Metalloproteinase-28 Deletion Exacerbates Cardiac Dysfunction and Rupture After Myocardial Infarction in Mice by Inhibiting M2 Macrophage Activation
Overview
Authors
Affiliations
Rationale: Matrix metalloproteinase (MMP)-28 regulates the inflammatory and extracellular matrix responses in cardiac aging, but the roles of MMP-28 after myocardial infarction (MI) have not been explored.
Objective: To determine the impact of MMP-28 deletion on post-MI remodeling of the left ventricle (LV).
Methods And Results: Adult C57BL/6J wild-type (n=76) and MMP null (MMP-28((-/-)), n=86) mice of both sexes were subjected to permanent coronary artery ligation to create MI. MMP-28 expression decreased post-MI, and its cell source shifted from myocytes to macrophages. MMP-28 deletion increased day 7 mortality because of increased cardiac rupture post-MI. MMP-28(-/-) mice exhibited larger LV volumes, worse LV dysfunction, a worse LV remodeling index, and increased lung edema. Plasma MMP-9 levels were unchanged in the MMP-28((-/-)) mice but increased in wild-type mice at day 7 post-MI. The mRNA levels of inflammatory and extracellular matrix proteins were attenuated in the infarct regions of MMP-28(-/-) mice, indicating reduced inflammatory and extracellular matrix responses. M2 macrophage activation was impaired when MMP-28 was absent. MMP-28 deletion also led to decreased collagen deposition and fewer myofibroblasts. Collagen cross-linking was impaired as a result of decreased expression and activation of lysyl oxidase in the infarcts of MMP-28(-/-) mice. The LV tensile strength at day 3 post-MI, however, was similar between the 2 genotypes.
Conclusions: MMP-28 deletion aggravated MI-induced LV dysfunction and rupture as a result of defective inflammatory response and scar formation by suppressing M2 macrophage activation.
Balaraman A, Altamimi A, Babu M, Goyal K, Padmapriya G, Bansal P Biogerontology. 2025; 26(1):46.
PMID: 39832057 DOI: 10.1007/s10522-025-10190-6.
IL-4-Induced Gene 1: A Potential Player in Myocardial Infarction.
Shen R, Ding Y, Dong Q, Wang Y, Yu J, Pan C Rev Cardiovasc Med. 2024; 25(9):337.
PMID: 39355609 PMC: 11440439. DOI: 10.31083/j.rcm2509337.
Kanuri B, Sreejit G, Biswas P, Murphy A, Nagareddy P iScience. 2024; 27(7):110274.
PMID: 39040061 PMC: 11261154. DOI: 10.1016/j.isci.2024.110274.
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.
Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X Signal Transduct Target Ther. 2024; 9(1):130.
PMID: 38816371 PMC: 11139930. DOI: 10.1038/s41392-024-01840-1.
Early Injury Landscape in Vein Harvest by Single-Cell and Spatial Transcriptomics.
Michaud M, Mota L, Bakhtiari M, Thomas B, Tomeo J, Pilcher W Circ Res. 2024; 135(1):110-134.
PMID: 38808504 PMC: 11189745. DOI: 10.1161/CIRCRESAHA.123.323939.